FGFR2 and breast neoplasm: We also investigated whether the FGFR2+ population is enriched for human breast tumor-initiating cells by monitoring aldehyde dehydrogenase (ALDH) activity since elevated ALDH activity has been shown in normal and malignant human mammary stem cells [47], [48].